लोड हो रहा है...

Belatacept for the prophylaxis of organ rejection in kidney transplant patients: an evidence-based review of its place in therapy

BACKGROUND: Belatacept is a novel immunosuppressive therapy designed to improve clinical outcomes associated with kidney transplant recipients while minimizing use of calcineurin inhibitors (CNIs). METHODS: We searched for clinical trials related to administration of belatacept to kidney transplant...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Int J Nephrol Renovasc Dis
मुख्य लेखकों: Hardinger, Karen L, Sunderland, Daniel, Wiederrich, Jennifer A
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2016
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4888760/
https://ncbi.nlm.nih.gov/pubmed/27307759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S88816
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!